Loading insider details...
Beta
Latest Form 4 (May 17, 2024): Grant/Award of 1,806 EFTR shares, $3.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 17, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 1,806 | $3.0K |
| Feb 21, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 80,000 | n/a |
| Nov 16, 2023 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 5,979 | $3.0K |
| Aug 14, 2023 | eFFECTOR Therapeutics, Inc. (EFTR) | Exercise/Conversion | 33,799 | $17.6K |
| May 16, 2023 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 6,401 | $2.9K |
| Jan 19, 2023 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 1,000,000 | n/a |
| Nov 16, 2022 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 6,047 | $2.8K |
| Jun 22, 2022 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 520,674 | n/a |
| Jun 9, 2022 | eFFECTOR Therapeutics, Inc. (EFTR) | Purchase | 20,000 | $27.4K |
| May 17, 2022 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 1,837 | $2.8K |